tiprankstipranks
Advertisement
Advertisement

SNDX Stock Latest News

Syndax Pharmaceuticals Earnings Call Signals Strong Momentum
Company AnnouncementsSyndax Pharmaceuticals Earnings Call Signals Strong Momentum
1d ago
SNDX
Syndax price target lowered to $40 from $44 at JPMorgan
PremiumThe Fly
Syndax price target lowered to $40 from $44 at JPMorgan
10d ago
SNDX
Syndax Buy Rating Reaffirmed as Analyst Sees Transitory Demand Weakness, Strong Menin Positioning and Pipeline Catalysts Supporting Unchanged $57 Target
PremiumRatings
Syndax Buy Rating Reaffirmed as Analyst Sees Transitory Demand Weakness, Strong Menin Positioning and Pipeline Catalysts Supporting Unchanged $57 Target
16d ago
SNDX
Syndax price target lowered to $38 from $40 at H.C. Wainwright
PremiumThe Fly
Syndax price target lowered to $38 from $40 at H.C. Wainwright
16d ago
SNDX
Phil Nadeau Reiterates Buy on Syndax, Citing Strong Revuforj Trajectory and Potential $2B Peak U.S. Sales
PremiumRatings
Phil Nadeau Reiterates Buy on Syndax, Citing Strong Revuforj Trajectory and Potential $2B Peak U.S. Sales
16d ago
SNDX
Syndax reports Q2 EPS (55c), consensus (44c)
PremiumThe FlySyndax reports Q2 EPS (55c), consensus (44c)
17d ago
SNDX
SNDX Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
SNDX Upcoming Earnings Report: What to Expect?
19d ago
SNDX
Syndax: Expanding Pipeline and Upcoming Axatilimab IPF Data Support Buy Rating and $29 Price Target Upside
Premium
Ratings
Syndax: Expanding Pipeline and Upcoming Axatilimab IPF Data Support Buy Rating and $29 Price Target Upside
1M ago
SNDX
Syndax: Strengthening Pipeline and R&D Outlook Support Buy Rating and Unchanged $34 Price Target
PremiumRatings
Syndax: Strengthening Pipeline and R&D Outlook Support Buy Rating and Unchanged $34 Price Target
1M ago
SNDX
Syndax: Advancing Menin Inhibitor and Fibrosis/Oncology Pipeline Supports High-Risk, High-Reward Buy Rating
PremiumRatings
Syndax: Advancing Menin Inhibitor and Fibrosis/Oncology Pipeline Supports High-Risk, High-Reward Buy Rating
1M ago
SNDX
Syndax: Expanding High-Potential Pipeline and Disciplined Strategy Support Unchanged $40 Price Target and Buy Rating
PremiumRatings
Syndax: Expanding High-Potential Pipeline and Disciplined Strategy Support Unchanged $40 Price Target and Buy Rating
1M ago
SNDX
Syndax Showcases Late-Stage Pipeline, Expands R&D Strategy
PremiumCompany Announcements
Syndax Showcases Late-Stage Pipeline, Expands R&D Strategy
1M ago
8K
SNDX
Syndax price target lowered to $31 from $34 at Guggenheim
PremiumThe FlySyndax price target lowered to $31 from $34 at Guggenheim
2M ago
KURA
SNDX
Syndax Buy Rating Reiterated as Revuforj Data Strengthens AML Profile; $40 Price Target Maintained
Premium
Ratings
Syndax Buy Rating Reiterated as Revuforj Data Strengthens AML Profile; $40 Price Target Maintained
2M ago
SNDX
Syndax presents data from SAVE trial at EHA
Premium
The Fly
Syndax presents data from SAVE trial at EHA
2M ago
SNDX
Syndax Pharmaceuticals Reports New Significant Financial Obligation Agreement
PremiumCompany Announcements
Syndax Pharmaceuticals Reports New Significant Financial Obligation Agreement
2M ago
8K
SNDX
Syndax Shareholders Approve 2026 Equity and ESPP Plans
PremiumCompany Announcements
Syndax Shareholders Approve 2026 Equity and ESPP Plans
2M ago
8K
SNDX
Analyst Reiterates Buy on Syndax, Sees Durable Revuforj Upside with Unchanged $34 Price Target
PremiumRatings
Analyst Reiterates Buy on Syndax, Sees Durable Revuforj Upside with Unchanged $34 Price Target
3M ago
SNDX
Syndax Pharmaceuticals Prices $250 Million Convertible Senior Notes
PremiumCompany Announcements
Syndax Pharmaceuticals Prices $250 Million Convertible Senior Notes
3M ago
8K
SNDX
Syndax announces $250M convertible senior note offering due 2031
PremiumThe FlySyndax announces $250M convertible senior note offering due 2031
3M ago
SNDX
Syndax price target lowered to $37 from $38 at UBS
Premium
The Fly
Syndax price target lowered to $37 from $38 at UBS
3M ago
SNDX
Syndax reports 12 Revuforj abstracts accepted for EHA
Premium
The Fly
Syndax reports 12 Revuforj abstracts accepted for EHA
3M ago
SNDX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >